HEALTHCARE · NSE/BSE: GPTHEALTH

GPT Healthcare Limited Earnings Summary — Q1 FY2027

Sentiment: Positive
AI-generated summary
Generated 2026-08-04
Generated using: Official Earnings Press Release
Business Intelligence Report

GPT Healthcare Posts 65% Net Profit Surge in Q1 FY2027 Amid Strong Operating Growth

Quarterly Business Intelligence

Q4 FY2026
Financials from Financial Intelligence · data as of 2026-03-31
Revenue
₹126 Cr
QoQ +5.2%YoY +24.6%
Net Profit
₹15 Cr
QoQ +55.5%YoY +13.0%
Operating Profit
₹23 Cr
QoQ +12.8%YoY +12.9%
Operating Margin
18.5%
QoQ +125 bpsYoY -192 bps

AI Quarterly Scorecard™

69
/ 100
Healthy
Revenue Momentum86
Profit Growth83
Margin Expansion40
Growth Consistency80
Operating Efficiency56
Financial Stability70

Computed deterministically from the last 10 reported quarters.

Quarterly Business Momentum

Revenue & Growth
  • Revenue has increased for 5 consecutive quarters.
  • Revenue of ₹126 Cr is 24.6% higher year-on-year.
  • Revenue has compounded at 12.7% annualised over the last 10 quarters.
  • Revenue is at its highest level in 10 quarters.
Profitability
  • Net profit of ₹15 Cr is 13.0% above the same quarter last year.
  • Profit growth is trailing revenue growth this quarter.
  • Net profit has compounded at 11.2% annualised across the period.
Margins
  • Operating margin stands at 18.5% in Q4 FY2026.
  • Operating margin compressed by 192 bps year-on-year.
  • Over the last two years operating margin has contracted by 481 bps.
  • PBT margin is 12.6%.
Operating Efficiency
  • Expenses grew 27.6% against revenue growth of 24.6%.
  • Operating profit of ₹23 Cr is 12.9% higher year-on-year.
  • Operating leverage has been under pressure recently.
Overall Momentum
  • 6 of the last 6 measured quarters delivered year-on-year revenue growth.
  • Overall quarterly business momentum scores 69/100 (Healthy) on the latest 10 quarters.
  • Business momentum remains positive heading into the next quarter.

Quarterly Financials

Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %

MetricTrend
Latest
Q4 FY2026
Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025Q4 FY2024Q3 FY2024
Revenue
Improving
126
120119107101102106989997
Expenses
Improving
103
999690818182807676
Operating Profit
Accelerating
23
212317212123182321
Operating Margin
Stable
18.5%
17.2%19.1%16.2%20.4%20.8%22.2%18.4%23.3%21.7%
Other Income
Improving
2
112223221
Interest
Improving
2
222111122
Depreciation
Improving
7
776555555
Profit Before Tax
Accelerating
16
131511161821151816
Tax
Softening
1
343356565
Net Profit
Accelerating
15
9118131215101311
Net Margin
Accelerating
11.5%
7.8%8.9%7.2%12.7%12.0%14.0%10.2%12.9%11.9%
Source: Financial Intelligence (Structured Quarterly Data)Latest Quarter: Q4 FY2026Figures in ₹ Crore • Margins in %Automatically updated from Financial Intelligence · 2026-03-31

Key Takeaways

  • Net Profit witnessed a significant year-over-year jump of 65.73% reaching ₹1,273.14 lakhs.
  • Revenue from operations grew 17.83% YoY to ₹12,620.43 lakhs, showcasing strong demand in regional healthcare markets.
  • Profit before tax (PBT) improved substantially to ₹1,716.47 lakhs compared to ₹1,111.36 lakhs in the same quarter last year.
  • Operating margins showed healthy expansion on a YoY basis, driven by better control over other expenses.
  • The company continues to operate as a single-segment entity focused on healthcare services in India.
  • Quarter-on-quarter performance showed a slight dip in net profit, primarily due to higher deferred tax adjustments in the prior quarter.

Management Guidance

Management remains focused on expanding the 'ILS Hospitals' footprint in under-served markets of Eastern India and Tripura, leveraging its regional cost control advantages.

Sentiment Shift

Improving

The sharp year-over-year growth in both top and bottom lines suggests the company is successfully scaling its patient volumes and clinical efficiency post-listing.

Growth-oriented
Operationally Efficient
Regional Focus

Outlook

The outlook remains positive as the company utilizes its strengthened balance sheet to drive brownfield expansions and improve bed occupancy across its existing 560+ bed capacity.

From the Annual Report (Key Quotes)

The Company operates in one single reportable business segment and geographical segment i.e. healthcare service in India.

The Board of Directors... have interalia considered, approved and taken on record the Un-audited financial results for the 1st quarter ended June 30, 2026.

Official Quarterly Documents

Earnings Press Release
Official quarterly earnings release published by the company.
Download
Earnings Call Transcript
Management discussion and analyst Q&A.

Ask AI about this quarter

Sign in to ask AI questions grounded on the official earnings release and call transcript.

This summary is AI-generated from GPT Healthcare Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.

← Back to GPT Healthcare Limited AI analysis